Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease
暂无分享,去创建一个
H. Neumann | B. Melchior | Angie Garcia | Bor-Kai Hsiung | K. M. Lo | Jonathan M. Doose | J. Cameron Thrash | A. Stalder | M. Staufenbiel | M. Carson
[1] K. Abromeit. Music Received , 2023, Notes.
[2] W. Hickey,et al. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. , 1988, Science.
[3] M. Carson,et al. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. , 1993, Neuron.
[4] M. Carson,et al. Insulin-like growth factor I increases brain growth and central nervous system myelination in tTransgenic mice , 1993, Neuron.
[5] C. Cotman,et al. Cultured Rat Microglia Express C1q and Receptor for C1q: Implications for Amyloid Effects on Microglia , 1995, Experimental Neurology.
[6] Brian J Cummings,et al. Localization and Cell Association of C1q in Alzheimer's Disease Brain , 1996, Experimental Neurology.
[7] B. Sommer,et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Sutcliffe,et al. Mature microglia resemble immature antigen‐presenting cells , 1998, Glia.
[9] E. Masliah,et al. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. , 1998, The American journal of pathology.
[10] V. Sanders,et al. Exacerbation of Facial Motoneuron Loss after Facial Nerve Transection in Severe Combined Immunodeficient (scid) Mice , 1999, The Journal of Neuroscience.
[11] J. Sutcliffe,et al. Microglia stimulate naive T‐cell differentiation without stimulating T‐cell proliferation , 1999, Journal of neuroscience research.
[12] M. Colonna,et al. A Dap12-Mediated Pathway Regulates Expression of Cc Chemokine Receptor 7 and Maturation of Human Dendritic Cells , 2001, The Journal of experimental medicine.
[13] M. Carson,et al. A Ligand for the Chemokine Receptor CCR7 Can Influence the Homeostatic Proliferation of CD4 T Cells and Progression of Autoimmunity1 , 2001, The Journal of Immunology.
[14] L. Lue,et al. Modeling microglial activation in Alzheimer’s disease with human postmortem microglial cultures , 2001, Neurobiology of Aging.
[15] S. Webster,et al. Antibody-Mediated Phagocytosis of the Amyloid β-Peptide in Microglia Is Differentially Modulated by C1q1 , 2001, The Journal of Immunology.
[16] J. Sutcliffe,et al. Heterogeneous expression of the triggering receptor expressed on myeloid cells‐2 on adult murine microglia , 2002, Journal of neurochemistry.
[17] Rong Fan,et al. Complement C1q expression induced by Aβ in rat hippocampal organotypic slice cultures , 2004, Experimental Neurology.
[18] T. Town,et al. Neuronal expression of CD22: Novel mechanism for inhibiting microglial proinflammatory cytokine production , 2004, Glia.
[19] Kathryn J. Jones,et al. CD4-Positive T Cell-Mediated Neuroprotection Requires Dual Compartment Antigen Presentation , 2004, The Journal of Neuroscience.
[20] M. Bianchin,et al. Nasu–Hakola Disease (Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy—PLOSL): A Dementia Associated with Bone Cystic Lesions. From Clinical to Genetic and Molecular Aspects , 2004, Cellular and Molecular Neurobiology.
[21] L. Tesson,et al. Identification of a New Member of the CD20/FcεRIβ Family Overexpressed in Tolerated Allografts , 2005 .
[22] H. Neumann,et al. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 , 2005, The Journal of experimental medicine.
[23] Arrigo Moglia,et al. Neuropsychological tests and functional nuclear neuroimaging provide evidence of subclinical impairment in Nasu-Hakola disease heterozygotes. , 2005, Functional neurology.
[24] Kathryn J. Jones,et al. Role of the immune system in the maintenance of mouse facial motoneuron viability after nerve injury , 2005, Brain, Behavior, and Immunity.
[25] L. Peltonen,et al. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. , 2005, Neurology.
[26] B. Becher,et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis , 2005, Nature Medicine.
[27] M. Ebara,et al. Role of Clast1 in development of cerebellar granule cells , 2006, Brain Research.
[28] Yaniv Ziv,et al. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood , 2006, Nature Neuroscience.
[29] C. Lemere,et al. Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans. , 2006, Rejuvenation research.
[30] L. Piccio,et al. Cutting Edge: TREM-2 Attenuates Macrophage Activation1 , 2006, The Journal of Immunology.
[31] B. Melchior,et al. CNS immune privilege: hiding in plain sight , 2006, Immunological reviews.
[32] M. Colonna,et al. The TREM receptor family and signal integration , 2006, Nature Immunology.
[33] Steffen Jung,et al. Control of microglial neurotoxicity by the fractalkine receptor , 2006, Nature Neuroscience.
[34] L. Lanier,et al. Cutting Edge: Inhibition of TLR and FcR Responses in Macrophages by Triggering Receptor Expressed on Myeloid Cells (TREM)-2 and DAP121 , 2006, The Journal of Immunology.
[35] B. Melchior,et al. Microglia and the control of autoreactive T cell responses , 2006, Neurochemistry International.
[36] H. Neumann,et al. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis , 2007, Journal of Neuroimmunology.
[37] L. Piccio,et al. Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitis , 2007, European journal of immunology.
[38] J. Koenigsknecht-Talboo,et al. Regulation of Microglial Phagocytosis and Inflammatory Gene Expression by Gas6 Acting on the Axl/Mer Family of Tyrosine Kinases , 2008, Journal of Neuroimmune Pharmacology.
[39] C. Geula,et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease , 2007, Nature Medicine.
[40] H. Neumann,et al. TREM2-Transduced Myeloid Precursors Mediate Nervous Tissue Debris Clearance and Facilitate Recovery in an Animal Model of Multiple Sclerosis , 2007, PLoS medicine.
[41] L. Peltonen,et al. Transcript profiles of dendritic cells of PLOSL patients link demyelinating CNS disorders with abnormalities in pathways of actin bundling and immune response , 2007, Journal of Molecular Medicine.
[42] Steffen Jung,et al. Microglia can be induced by IFN-γ or IL-4 to express neural or dendritic-like markers , 2007, Molecular and Cellular Neuroscience.
[43] I. Bechmann,et al. TREM2 is upregulated in amyloid plaque‐associated microglia in aged APP23 transgenic mice , 2008, Glia.
[44] R. Schmidt,et al. Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. , 2008, Brain : a journal of neurology.
[45] Bruce E. Torbett,et al. Developmental Regulation of TREM2 and DAP12 Expression in the Murine CNS: Implications for Nasu-Hakola Disease , 2008, Neurochemical Research.
[46] J. Kipnis,et al. Adaptive immunity affects learning behavior in mice , 2008, Brain, Behavior, and Immunity.
[47] E. Chouery,et al. Mutations in TREM2 lead to pure early‐onset dementia without bone cysts , 2008, Human mutation.
[48] A. Tenner,et al. Complement component C1q inhibits β‐amyloid‐ and serum amyloid P‐induced neurotoxicity via caspase‐ and calpain‐independent mechanisms , 2007, Journal of neurochemistry.
[49] H. Neumann,et al. Signal regulatory protein-beta1: a microglial modulator of phagocytosis in Alzheimer's disease. , 2009, The American journal of pathology.
[50] J. Meldolesi,et al. The surface‐exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor , 2009, Journal of neurochemistry.
[51] V. Yong,et al. Taking Advantage of the Systemic Immune System to Cure Brain Diseases , 2009, Neuron.
[52] C. Gahmberg,et al. Neuronal regulation of immune responses in the central nervous system. , 2009, Trends in immunology.
[53] B. Uitdehaag,et al. Restoring immune suppression in the multiple sclerosis brain , 2009, Progress in Neurobiology.
[54] H. Kettenmann,et al. C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation , 2009, Journal of neuroscience research.
[55] M. Graeber,et al. Microglia: biology and pathology , 2009, Acta Neuropathologica.
[56] M. Carson,et al. When the tail can't wag the dog: the implications of CNS-intrinsic initiation of neuroinflammation , 2009, ASN neuro.
[57] W. Seaman,et al. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia , 2009, Journal of neurochemistry.
[58] M. Staufenbiel,et al. Journal of Neuroinflammation BioMed Central , 2008 .
[59] B. Melchior,et al. Differential gene expression in LPS/IFNγ activated microglia and macrophages: in vitro versus in vivo , 2009, Journal of neurochemistry.
[60] C. Colton,et al. Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice. , 2009, CNS & neurological disorders drug targets.
[61] M. Colonna,et al. TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria , 2009, The Journal of cell biology.
[62] Sarah L. Brown,et al. Efficient colonic mucosal wound repair requires Trem2 signaling , 2009, Proceedings of the National Academy of Sciences.
[63] F. Heppner,et al. Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia , 2009, Nature Neuroscience.
[64] S. Skaper,et al. The P2X7 purinergic receptor: from physiology to neurological disorders , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[65] Brent D. Cameron,et al. Inflammation, microglia, and alzheimer's disease , 2010, Neurobiology of Disease.
[66] Richard M. Page,et al. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease , 2010, Nature Neuroscience.
[67] F. Heppner,et al. Formation and maintenance of Alzheimer’s disease beta-amyloid plaques in the absence of microglia , 2010 .
[68] P. Mcgeer,et al. Inflammation in transgenic mouse models of neurodegenerative disorders. , 2010, Biochimica et biophysica acta.
[69] J. Kipnis,et al. Rett syndrome and other autism spectrum disorders—brain diseases of immune malfunction? , 2010, Molecular Psychiatry.
[70] A. Nemirovsky,et al. T Cells Specifically Targeted to Amyloid Plaques Enhance Plaque Clearance in a Mouse Model of Alzheimer's Disease , 2010, PloS one.
[71] S. McMahon,et al. P2X7-Dependent Release of Interleukin-1β and Nociception in the Spinal Cord following Lipopolysaccharide , 2010, The Journal of Neuroscience.
[72] B. Khakh,et al. P2X4 receptors in activated C8-B4 cells of cerebellar microglial origin , 2010, The Journal of general physiology.
[73] B. Melchior,et al. A rose by any other name? the potential consequences of microglial heterogeneity during CNS health and disease , 2007, Neurotherapeutics.